Intelligent Medicine Acquisition Corp. Class A Common Stock
IQMD
IQMD was delisted on the 26th of April, 2023.
8 hedge funds and large institutions have $5.26M invested in Intelligent Medicine Acquisition Corp. Class A Common Stock in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 55 closing their positions.
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
87% less funds holding
Funds holding: 61 → 8 (-53)
87.51% less ownership
Funds ownership: 94.5% → 6.99% (-88%)
96% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 55
97% less capital invested
Capital invested by funds: $201M → $5.26M (-$196M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CF
Cantor Fitzgerald
New York
|
+$10.6M |
| 2 |
CS
Clear Street
New York
|
+$179K |
| 3 |
Walleye Capital
New York
|
+$89.6K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Saba Capital Management
New York
|
-$22.3M |
| 2 |
Calamos Advisors
Naperville,
Illinois
|
-$12.8M |
| 3 |
HCM
Highbridge Capital Management
New York
|
-$9.48M |
| 4 |
HIM
HGC Investment Management
Toronto,
Ontario, Canada
|
-$8.22M |
| 5 |
D.E. Shaw & Co
New York
|
-$8.09M |
IQMD Hedge Fund Activity: Q1 2023 in Review
8 of the 6,284 institutional investors tracked by Wall St. Rank reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) for Q1 2023, worth a combined $5.26M — down 97% from $201M a quarter earlier.
Sellers outnumbered buyers: 55 funds closed out of IQMD and 2 opened new positions — a net loss of 53 holders — while 3 trimmed existing stakes and 2 added.
The largest buyer was Cantor Fitzgerald, opening a new position worth an estimated $10.6M. The largest seller was Saba Capital Management, exiting entirely with an estimated $22.3M sold.
- 8 institutional investors held Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) as of Q1 2023, down from 61 in Q4 2022.
- Funds reported $5.26M of Intelligent Medicine Acquisition Corp. Class A Common Stock stock for Q1 2023, down 97% quarter-over-quarter.
- 2 funds opened new Intelligent Medicine Acquisition Corp. Class A Common Stock positions in Q1 2023 and 55 closed out, a net change of -53 holders.
- The largest Intelligent Medicine Acquisition Corp. Class A Common Stock buyer in Q1 2023 was Cantor Fitzgerald, an estimated $10.6M added.
- The largest Intelligent Medicine Acquisition Corp. Class A Common Stock seller in Q1 2023 was Saba Capital Management, an estimated $22.3M sold.
Based on aggregated 13F filings for Q1 2023.